|
|
|
市場調査レポート
医療用診断キット市場
Medical Diagnostic Kits
|
Abstract
This report:
- Describes the products that comprise the Medical Diagnostic Kits (MDK)
industry
- Details emerging and current MDK technologies
- Analyzes these technologies and their impact on future products and market
growth
- Evaluates market structure and current market size with forecasts through
2013 with specific emphasis on each segment
- Addresses the effects of external market forces, such as insurance,
regulatory and economic issues and increased incidence of disease.
Introduction
STUDY GOALS AND OBJECTIVES
This study, Medical Diagnostic Kits (MDKs), provides the reader with an
intensive examination of the in vitro medical diagnostic kit segment of the
medical device market. It will specifically address the changes that have
occurred as the result of technological advances and regulatory
implementations from 2002 to 2007, and the impact these changes will have on
the overall market and key market segments.
Beyond focusing on these changes, this report will define the entire MDK
industry, including its structure and dynamics. The report will also discuss
the major players, their relative market shares, the impact of external market
forces, and implications for current and emerging technologies.
REASONS FOR DOING THE STUDY
Significant changes have occurred in the MDK market since BCC Research last
examined the market in 2002. The market for analytical test kits packaged for
use on a single-test basis to test for a wide variety of substances has been
affected by dramatic changes in the global environment, as well as changes in
demographics and national security issues within the United States.
Significant changes include the following:
- An extremely large aging population of 78 million so-called "Baby Boomers"
- Increasing rates of various types of cancer
- Continued threat of bioterrorism through chemical/biological methods
- An ever-increasing at-risk population of individuals with diabetes,
hepatitis, and human papillomavirus
- A slow down in HIV/AIDS diagnosed cases
- A virtual epidemic of substance abuse
- Introduction of infectious diseases from global migrations of people
- Re-introduction of infectious diseases such as syphilis, tuberculosis, and
measles, thought to be vanquished.
This report will identify and examine these marketplace trends and forecast
future market changes from 2007 through 2013.
The current marketplace is highly competitive among established companies and
new entrants expanding the variety of tests available as MDKs. To
differentiate their products from competitors, new technologies and innovative
marketing strategies are being used.
In addition to the expansion of the market through new tests, the MDK market
is also affected by the development of inexpensive, automated testing devices,
known as point-of-care (POC) instruments, which have replaced MDKs in smaller
laboratories and physicians' offices. This trend is definitely present in the
clinical testing and veterinary markets. Additionally, clinical testing is
being affected by the introduction of automated suites of instruments designed
to increase the processing of diagnostic assay kits. All of the major
manufacturers of MDKs now have automated suites of instrumentation for the
clinical, research, and veterinary markets.
INTENDED AUDIENCE
This study of the competitive and evolving MDK industry will be beneficial to
diagnostic industry participants holding marketing, management, and technical
development positions. It will also benefit readers who are suppliers to this
industry. Additionally, investors, venture capitalists, insurance companies,
and those interested in diagnostic medical testing will find this report
valuable.
SCOPE OF REPORT
All products classified as MDKs are found in this report. These include
products prepackaged for in vitro manual testing (whether the end point is
detected by the naked eye or by using a reading device). The report
specifically excludes tests that involve automated testing or tests that
require processing devices and semi-automated batch testing devices.
The MDK market encapsulates current and potential products, related
technologies, components and component suppliers, end markets, governmental
and regulatory agencies, major companies competing in this market, relative
market shares, and the impact of the worldwide market status.
This study defines the MDK market and provides detailed information on the
following:
- Products that comprise the MDK industry
- Emerging and current MDK technologies
- Analysis of these technologies and their effect on future products and
market growth
- Market structure and current market size, with forecasts through 2013, by
each segment
- Current market dynamics and trends
- Emerging marketing practices, such as strategic alliances and acquisitions
- The effect of external market forces, such as insurance, regulatory and
economic issues, and increased incidence of disease
- Internal aspects of the industry
- Specific opportunities for industry participants and industry suppliers
INFORMATION SOURCES
Information sources for this report include company websites and product
literature, financial analyst reports, industry association members, and
industry sources.
The primary data collection methodology for this report focuses on information
provided by industry personnel, through Web-based sources or interviews,
government agencies, industry observers, and industry professional
organizations. In addition to these primary data sources, secondary data
research techniques include a literature search of medical, government, and
business libraries.
All data collected were analyzed by BCC personnel to determine specific
findings and to make forecasts. Once these forecasts were obtained, they were
validated by consultation with industry experts. Consequently, all estimates
provided in this report represent a consensus opinion of BCC personnel,
industry participants, and industry observers.
Growth forecasts are made in constant 2007 dollars based on the U.S.
manufacturers' (wholesale) price levels, unless otherwise noted.
Table of Contents
Chapter- 1: SUMMARY
- REPORT HIGHLIGHTS
- SUMMARY TABLE PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, THROUGH
2013 ($ MILLIONS)
- SUMMARY FIGURE PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, 2007- 2013 ($
MILLIONS)
Chapter- 2: THE MDK INDUSTRY
- WHAT ARE MDKS?
- ADVANTAGES OF MDKS
- USES FOR MDKS
- CLINICAL TESTING
- Clinical Diagnostic Testing
- Monitoring
- Screening
- Confirmatory Testing
- RESEARCH
- HOME USE
- VETERINARY DIAGNOSIS
- MARKET SIZE
- TABLE 1 PROJECTED U.S. MDK MARKET COMPARED WITH THE TOTAL DIAGNOSTIC
TESTING INDUSTRY, THROUGH 2013 ($ BILLIONS)
- RELATION TO TOTAL TESTING MARKET
- FIGURE 1 MDK' S RELATIVE SHARE OF U.S. TESTING MARKET PROJECTED, THROUGH
2013 ($ BILLIONS)
- ALTERNATIVE METHODS
- TABLE 2 ALTERNATIVE METHODS TO MDKS AND AREA OF PRIMARY USE
- Chemical Assay
- Culture
- Microscopy
- Biological Assay
- Chromatographic Separation
- MDK APPLICATIONS
- TABLE 3 SELECTED MDK APPLICATIONS
- INDUSTRY STRUCTURE
- REAGENTS
- DEVICE/CARRIER
- PACKAGING
- COMPONENT SUPPLIERS
- FIGURE 2 COMPONENTS OF AN MDK
- TABLE 4 SELECTED LISTING OF MDK COMPONENT SUPPLIERS BY AREA OF
PARTICIPATION
- END MARKETS
- TABLE 5 MDK APPLICATIONS BY END-USE FACILITY
- CLINICAL TESTING FACILITIES
- TABLE 6 U.S. CLINICAL TESTING FACILITIES WITH POTENTIAL FOR USING MDKS:
CLIA VS. NON-CLIA
- CLIA-Certified Laboratories
- Non-CLIA Laboratories/Facilities
- RESEARCH LABORATORIES
- HOME-USE MARKET
- VETERINARY APPLICATIONS
- TABLE 7 SELECTED LISTING OF ANIMAL TESTING MDKS
- INTERNAL MARKET FORCES, EXTERNAL MARKET FORCES
- TRADE PRACTICES
- Promotion
- Pricing
- Sales Tie-ins
- INDUSTRY CHANNELS OF DISTRIBUTION
- FIGURE 3 CHANNELS OF DISTRIBUTION FOR MDKS
- STRATEGIC ALLIANCES
- ACQUISITIONS
- TABLE 8 SELECTED COMPANY ACQUISITIONS, 1995-2008
- TABLE 8 (CONTINUED)
- STRATEGIES IN CONSUMER ADVERTISING
- EXTERNAL MARKET FORCES
- FIGURE 4 EXTERNAL MARKET FACTORS AFFECTING THE MDK INDUSTRY
- REGULATORY
- Food and Drug Administration (FDA)
- Clinical Laboratory Improvement Amendments
- Clinical Laboratory Improvement ...(Continued)
- Clinical Laboratory Improvement ...(Continued)
- TABLE 9 CLIA WAIVED TESTS
- TABLE 9 (CONTINUED)
- Good Manufacturing Practice
- TABLE 10 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING MDKS
- COST CONTAINMENT EFFORTS
- Diagnosis Related Groups (DRGs)
- Medicare
- Third-Party Payers
- Physician Ownership/Referral Clinical Laboratory Services
- CHANGES IN THE INCIDENCE OF DISEASE
- TABLE 11 PREVALENCE OF SELECTED DISEASES IN THE U.S. POPULATION*
(THOUSANDS OF CASES)
- FIGURE 5 U.S. POPULATION BY AGE BRACKET, 2005 AND 2010
- TRENDS IN POINT-OF-CARE TESTING
- TABLE 12 SELECTED LISTING OF CURRENTLY MARKETED POC DEVICES
- TABLE 13 PROJECTED U.S POINT-OF-CARE DEVICE MARKET, THROUGH 2013 ($
BILLIONS)
- I-STAT SYSTEM
- ABAXIS PICCOLO SYSTEM
- INTERNATIONAL ASPECTS OF MDK MARKET
- PRESENCE OF U.S. MANUFACTURERS IN THE WORLDWIDE MARKET
Chapter- 3: TECHNOLOGICAL ASPECTS OF MDK INDUSTRY
- TESTING METHODS
- TABLE 14 MAJOR MDK APPLICATIONS BY TYPE OF TECHNOLOGY
- TABLE 14 (CONTINUED)
- CHEMICAL ANALYSIS
- ENZYMATIC ANALYSIS
- IMMUNOLOGICAL ANALYSIS
- ENZYME IMMUNOASSAY
- Basic EIA
- FIGURE 6 THE BASIC ENZYME IMMUNOASSAY (EIA) PROCESS
- Alternative EIA Methods
- SECOND-ANTIBODY PRECIPITATION METHOD
- DOUBLE-ANTIBODY SANDWICH METHOD
- REVERSE-SANDWICH METHOD
- REVERSE-SANDWICH INHIBITION METHOD
- FLUORESCENCE IMMUNOASSAY
- Direct FA
- Indirect FA
- LATEX AGGLUTINATION
- RADIOIMMUNOASSAY
- Limitations to RIA Testing
- Types of RIA Methods
- IMMUNOPRECIPITATION/AGGLUTINATION
- GENE PROBE ANALYSIS
- Gene Probes
- Gene Probe Glossary
- TYPES OF HYBRIDIZATION COMMONLY USED
- Gel Electrophoresis/Southern Blot Method
- HYBRIDIZATION IN SOLUTIONS
- Solid Support Methods
- DNA ARRAY TECHNOLOGY
- AMPLIFICATION
- Importance of Amplification in the Development of Probes
- TARGET AMPLIFICATION TECHNIQUES
- Polymerase Chain Reaction Amplification
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Strand-Displacement Amplification
- Transcription-Mediated Amplification
- PROBE AMPLIFICATION
- Q-Beta Replicase
- Ligase Chain Reaction
- Cycling Probe Technology
- SIGNAL AMPLIFICATION
- Branched DNA Assay
- MDK FEATURES AFFECTING MARKETABILITY
- RELIABILITY AND ACCURACY
- RANGE OF MEASUREMENT AND SENSITIVITY
- STORAGE STABILITY
- EASE OF USE
Chapter- 4: CLINICAL MDK APPLICATIONS
- SEGMENTS
- TABLE 15 PROJECTED U.S. MDK MARKET BY END-USE SEGMENT, THROUGH 2013 ($
MILLIONS)
- CLINICAL LABORATORY APPLICATIONS
- INFECTIOUS DISEASE TESTING
- TABLE 16 SELECTED LISTING OF BACTERIA FOUND IN CLINICAL SPECIMENS AND
THE DISEASES THEY CAUSE
- TABLE 17 MAJOR VIRAL INFECTIOUS AGENTS
- Importance of Testing
- Clinical Testing Methods
- TYPES OF MDKS FOR INFECTIOUS DISEASE TESTING
- Immunodiagnostic Kits
- DipSticks
- Microbial and Rapid-Test Kits
- TABLE 18 SELECTED LISTING OF FDA APPROVED INFECTIOUS DISEASE TESTING
MDKS BY TYPE OF ASSAY
- TABLE 18 (CONTINUED)
- TABLE 18 (CONTINUED)
- TABLE 18 (CONTINUED)
- Gene Probe Kits
- MARKET SIZE
- TABLE 19 PROJECTED MDKS MARKET FOR INFECTIOUS DISEASE TESTING BY
APPLICATION, THROUGH 2013 ($ MILLIONS)
- MARKET DYNAMICS
- HIV/AIDS Testing
- Leading Market Participants
- Tuberculosis and Other Mycobacterium Infections
- MTD-Direct Detection of Mycobacterium Tuberculosis
- Confirmatory Gene Probe Kit Tests for Mycobacteria Species
- SEXUALLY TRANSMITTED DISEASES (STDS)
- Syphilis
- Gonorrhea
- TABLE 20 ANNUAL INCIDENCE OF SEXUALLY TRANSMITTED DISEASES IN THE U.S.,
2006*
- Chlamydia
- Human Papillomavirus
- Genital Herpes
- STREPTOCOCCI
- HEPATITIS
- DRUG TESTING
- TYPES OF DRUGS
- MARKET SIZE
- TABLE 21 PROJECTED U.S. MDK DRUG TESTING MARKET, THROUGH 2013 ($
MILLIONS)
- MDK APPLICATIONS IN DRUG TESTING
- Therapeutic Monitoring
- Diagnosing Overdoses
- Differential Diagnosis
- Detecting Drug Abuse
- TABLE 22 SELECTED LISTING OF DRUG TESTING MDKS CURRENTLY MARKETED BY
COMPANY
- ALTERNATIVES TO MDKS
- HOME-DETECTION METHODS
- TYPES OF DRUG TESTING MDKS
- HORMONES
- Diagnostic Benefits of Hormone Analysis
- Types of Hormone MDK Tests
- Hypothalamus
- Pituitary
- Thyroid
- Parathyroid
- Adrenal Glands
- Pancreas
- Brain Peptides
- HORMONE TESTS MARKETED
- TABLE 23 SELECTED LISTING OF HORMONE MDKS BY COMPANY
- Market Size
- TABLE 24 PROJECTED U.S. MDK HORMONE TESTING MARKET, THROUGH 2013 ($
MILLIONS)
- ALTERNATIVES TO MDKS
- CANCER TESTING
- Incidence of New Cancer Cases Annually
- TABLE 25 INCIDENCE OF NEW CANCER CASES IN THE U.S., 2006 AND 2007 (PER
ANNUM)
- Detection of Cancer
- MDKs for Cancer Testing
- TABLE 26 SELECTED LISTING OF CANCER DIAGNOSTICS AND THERAPEUTIC
MANAGEMENT MDK TESTS*
- Market Size and Structure
- TABLE 27 PROJECTED U.S. MARKET FOR CANCER DIAGNOSTIC MDKS: NON-RESEARCH
TESTING APPLICATIONS, THROUGH 20013 ($ MILLIONS)
- BLOOD/URINE CHEMISTRY TESTING
- Market Size and Structure
- TABLE 28 PROJECTED U.S. BLOOD/URINE CHEMISTRY MDK MARKET, THROUGH 2013
($ MILLIONS)
- AUTOMATION VERSUS MDKS
- POINT-OF-CARE (POC) ANALYTICAL SYSTEMS USING MDKS
- TYPES OF MDKS
- TABLE 29 CLIA APPROVED MDKS FOR BLOOD/URINE CHEMISTRY TESTING BY
COMPANY, 2002-2007
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- TABLE 29 (CONTINUED)
- Dipsticks
- EMERGING MDKS FOR CLINICAL TESTING
- Biochips
- Reporter Genes
- Automatic Sequencing
Chapter- 5: HOME-USE TESTING MARKET
- MARKET SIZE AND STRUCTURE
- TABLE 30 PROJECTED U.S. HOME-USE MDK MARKET BY TYPE OF TEST, THROUGH
2013 ($ MILLIONS)
- HOME-USE MDK MARKET PARTICIPANTS
- TABLE 31 SELECTED COMPANIES MARKETING HOME-USE MDK TESTS
- BY TEST TYPE
- MAJOR HOME-USE MDK SEGMENTS
- HOME PREGNANCY AND OVULATION TESTING
- Market Size
- TABLE 32 PROJECTED U.S. HOME-USE PREGNANCY AND OVULATION TESTING MDK
MARKET, THROUGH 2013 ($ MILLIONS)
- Market Participants
- GLUCOSE MONITORING
- Market Size
- TABLE 33 PROJECTED U.S. HOME-USE GLUCOSE TESTING MDK MARKET, THROUGH
2013 ($ MILLIONS)
- CHOLESTEROL TESTING
- Market Size
- TABLE 34 PROJECTED U.S. HOME-USE CHOLESTEROL TESTING MDK MARKET, THROUGH
2013 ($ MILLIONS)
- HIV/HEPATITIS TESTING
- FECAL OCCULT BLOOD TESTING
- Market Size
- URINARY OCCULT BLOOD/URINARY INFECTION TESTING
- Urinary Infection Testing
- DRUG TESTING
- Market Size
- Regulatory Environment
Chapter- 6: U.S. RESEARCH APPLICATIONS
- MARKET STRUCTURE
- MARKET SIZE
- TABLE 35 PROJECTED U.S. RESEARCH MDK MARKET, THROUGH 2013 ($ MILLIONS)
- RESEARCH AREAS
- EPIGENETICS
- PCR-BASED ASSAYS
- GENE MAPPING
- Gene Probes
- Molecular Biology
- TABLE 36 SELECTED TYPES OF MDKS MARKETED FOR MOLECULAR BIOLOGY RESEARCH
- TABLE 37 PROJECTED U.S. MOLECULAR DIAGNOSTIC MDK MARKET, THROUGH 2013 ($
MILLIONS)
Chapter- 7: VETERINARY APPLICATIONS
- VETERINARY MEDICINE
- CHANGES IN THE PRACTICE OF DOMESTIC VETERINARY MEDICINE
- MARKET SIZE AND STRUCTURE
- TABLE 38 PROJECTED U.S. VETERINARY TESTING MDK MARKET, THROUGH 2013 ($
MILLIONS)
- TABLE 39 DEMAND FOR VETERINARY CARE FOR DOMESTIC PETS, THROUGH 2013
(VISITS PER YR/PETS IN MILLIONS)
- IMPACT OF AUTOMATED VETERINARY SYSTEMS
- MARKET PARTICIPANTS
- VETERINARY MDKS
- FELINE LEUKEMIA VIRUS
- TABLE 40 SELECTED LISTING OF VETERINARY MDKS AND SUPPLIERS FOR COMPANION
ANIMALS-CANINE, FELINE, AVIAN, EQUINE
- TABLE 41 SELECTED LISTING OF VETERINARY MDKS AND SUPPLIERS FOR LIVESTOCK
ANIMALS (AVIAN, BOVINE, SWINE, EQUINE)
- CANINE HEARTWORM
- FELINE HEARTWORM
- FELINE IMMUNODEFICIENCY VIRUS (FIV)
- CANINE PARVOVIRUS
- PROGESTERONE
- JOHNE' S DISEASE
- CHEMISTRY TESTS
Chapter- 8: APPENDIX I CLIA WAIVED TESTS: 2002・ 007
- TABLE 42 CLIA WAIVED TESTS: 2002-2007
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
- TABLE 42 (CONTINUED)
Chapter- 9: APPENDIX II COMPANY PROFILES
- ABBOTT LABORATORIES
- ALFA SCIENTIFIC DESIGNS
- BAYER AG (MILES-BAYER)
- BECKMAN COULTER
- BECTON DICKINSON
- BIOMERIEUX
- BIO-RAD LABORATORIES
- GEN-PROBE
- GENZYME
- HESKA CORP.
- HOME ACCESS HEALTH
- IDEXX LABORATORIES
- INBIOS INTERNATIONAL
- INNOVACON (FORMERLY ACON LABORATORIES)
- INVERNESS MEDICAL INNOVATIONS
- INVITROGEN
- JOHNSON & JOHNSON
- LIFESIGN, LLC
- PHAMATECH
- QIAGEN
- QUIDEL
- REMEL
- ROCHE DIAGNOSTICS
- THERMOFISHER SCIENTIFIC
Chapter- 10: APPENDIX III COMPANIES BY PRODUCT TYPE
- TABLE 43 COMPANIES BY PRODUCT TYPE
- TABLE 43 (CONTINUED)
- TABLE 43 (CONTINUED)
Chapter- 11: APPENDIX IV DIRECTORY OF MDK COMPANIES
- AMDL, INC.
- ABBOTT LABORATORIES
- ACCUTECH, LLC
- ACON INTERNATIONAL
- AERSCHER DIAGNOSTICS
- ALFA SCIENTIFIC DESIGNS, INC.
- AMERICAN MICROSCAN
- AMNISURE INTERNATIONAL, LLC
- ANALYTAB PRODUCTS (BIOMERIEUX)
- APEX BIOTECHNOLOGY CORP.
- APPLIED BIOSYSTEMS
- ARMKEL, LLC
- BAYER AG
- BECKMAN COULTER
- BECTON DICKINSON
- BETHAM CORP.
- BINAX
- BIOMERICA, INC.
- BIOMERIEUX, INC.
- BIO-RAD LABORATORIES, INC.
- BIOSAFE MEDICAL TECHNOLOGIES, INC.
- BIOSITE
- BIOTECX
- BIOWHITTAKER, INC.
- BOEHRINGER MANNHEIM
- CEPHEID
- CENOGENICS CORP.
- CHEMATICS, INC.
- CHIRON CORP.
- CHOLESTECH CORP.
- CLONTECH LABORATORIES, INC.
- CHROMOGENIC MEDIA
- CHRONIMED
- CUNO, INC.
- DNA TECHNOLOGIES
- DADE BEHRING, INC.
- DIAGNOSTIC PRODUCTS
- ENZO LIFE SCIENCES, INC.
- EPICENTRE TECHNOLOGIES
- FILTERTEK, INC.
- FIRST CHECK DIAGNOSTICS
- FORT DODGE ANIMAL HEALTH
- GDS TECHNOLOGY, INC.
- GEN-PROBE
- GENZYME DIAGNOSTICS
- GERMAINE LABORATORIES
- GI SUPPLY
- GLAXO SMITHKLINE
- GLUCO PLUS
- W.L. GORE AND ASSOCIATES, INC.
- HARLAN BIOPRODUCTS FOR SCIENCE, INC.
- HELENA LABORATORIES
- HENRY SCHEIN, INC.
- HESKA CORP.
- HOME ACCESS HEALTH
- HOME DIAGNOSTICS, INC.
- ID BIOMEDICAL
- IDEXX LABORATORIES
- IMMUNOSTICS, INC.
- INBIOS INTERNATIONAL, INC.
- INCYTE
- INOVA DIAGNOSTICS
- INNOVACON
- INTERFLOW TECHNOLOGIES
- INTERNATIONAL TECHNIDYNE CORP. (ITC)
- INVERNESS MEDICAL INNOVATIONS
- INVITROGEN
- J&S MEDICAL ASSOCIATES, INC.
- JANT PHARMACAL
- JOHNSON & JOHNSON
- KIMBERLY CLARK/BALLARD
- LIFESIGN, LLC
- LITMUS CONCEPTS
- LXN CORP.
- MATRITECH, INC.
- MEDICAL ANALYSIS SYSTEMS, INC.
- MEDISENSE, INC.
- MEDITEST, INC.
- MERIDIAN BIOSCIENCE
- MILLIPORE CORP.
- MYRIAD GENETICS, INC.
- NOVAGEN
- NOVEX
- ORASURE TECHNOLOGIES
- PALL CORP.
- PHAMATECH
- PHARMANETICS, INC.
- POLYMEDCO, INC.
- POLYMER TECHNOLOGY SYSTEMS, INC.
- PORETICS CORP.
- PRINCETON BIOMEDITECH CORP.
- PSYCHEMEDICS CORP.
- QIAGEN, INC.
- QUANTUM BIOTECHNOLOGIES, INC.
- QUIDEL
- REDWOOD TOXICOLOGY LABORATORY, INC.
- REMEL, INC.
- ROCHE DIAGNOSTIC CORP.
- SA SCIENTIFIC, INC.
- STC TECHNOLOGIES, INC.
- SANOFI DIAGNOSTICS PASTEUR, INC.
- SERADYN
- SERIM RESEARCH CORP.
- SIEMENS HEALTHCARE DIAGNOSTICS, INC.
- SIGMA-ALDRICH
- SPECTRAL DIAGNOSTICS
- STANBIO LABORATORY
- STRATAGENE
- STRECK
- SYNBIOTICS
- SYNTRON BIORESEARCH
- SYVA/BEHRING DIAGNOSTICS
- TAIDOC TECHNOLOGY
- TECO DIAGNOSTICS
- TETKO, INC.
- THERASENSE
- THERMO BIOSTAR, INC.
- THERMOFISHER SCIENTIFIC
- UNIPATH
- WAKO CHEMICALS USA
- ZEUS SCIENTIFIC, INC.
|
 |
